In focus
Latest feed
AstraZeneca's Bold Bet: Charging Hard into China's Obesity Drug Race and Beyond
Vinay Prasad Sounds the Alarm: Media Missteps and Harvard’s Choices Are Hurting Biotech
A Vital Step Forward: Sarepta's Duchenne Drug Secures Key Testing Clearance
The Unfolding Saga of GLP-1 Drugs: A Potential Game-Changer for Alzheimer's?
